A number of new drugs were approved by the National Centre for Pharmacoeconomics but their release was stalled due to lack of funds
Included in this list are medications for the treatment of stroke and multiple sclerosis.
The agreement will put in place savings which will allow the HSE to cover the cost of the new medicines
NAI welcomes this development as a positive step to allowing access to new treatments for people with neurological conditions